We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+9.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.48B
AUM Growth
+$152M
Cap. Flow
+$58.2M
Cap. Flow %
2.35%
Top 10 Hldgs %
26.38%
Holding
291
New
33
Increased
134
Reduced
93
Closed
18

Sector Composition

Rank Sector Weight
1 Healthcare 24.68%
2 Technology 21.94%
3 Industrials 17.48%
4 Consumer Discretionary 13.63%
5 Communication Services 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWE
26
DELISTED
World Wrestling Entertainment
WWE
$31.9M 1.29%
788,097
+34,527
+5% +$1.51M
MTN icon
27
Vail Resorts
MTN
$5.3B
$30.7M 1.24%
143,473
+6,567
+5% +$1.35M
SSTK icon
28
Shutterstock
SSTK
$219M
$30.6M 1.23%
588,344
-3,890
-0.7% -$185K
RDWR icon
29
Radware
RDWR
$1.19B
$29.6M 1.19%
1,220,705
+67,891
+6% +$1.72M
RVNC
30
DELISTED
Revance Therapeutics, Inc.
RVNC
$28.4M 1.14%
1,130,016
+96,737
+9% +$2.54M
AX icon
31
Axos Financial
AX
$5.68B
$27.6M 1.11%
1,185,154
+76,477
+7% +$1.75M
ON icon
32
ON Semiconductor
ON
$31.6B
$26M 1.05%
1,196,892
+77,962
+7% +$1.65M
IOVA icon
33
Iovance Biotherapeutics
IOVA
$2.87B
$24.4M 0.98%
739,870
+59,933
+9% +$1.84M
COLL icon
34
Collegium Pharmaceutical
COLL
$956M
$23.1M 0.93%
1,108,219
+111,601
+11% +$2.01M
KPTI icon
35
Karyopharm Therapeutics
KPTI
$48M
$21.2M 0.86%
97,015
+46,227
+91% +$11.3M
SUPN icon
36
Supernus Pharmaceuticals
SUPN
$2.77B
$21M 0.85%
1,009,614
+84,128
+9% +$1.91M
ECHO
37
DELISTED
Echo Global Logistics, Inc.
ECHO
$21M 0.85%
816,089
+22,159
+3% +$569K
SIMO icon
38
Silicon Motion
SIMO
$8.68B
$20.7M 0.84%
548,813
+392,155
+250% +$15.7M
PBH icon
39
Prestige Consumer Healthcare
PBH
$2.6B
$20M 0.8%
547,952
+20,380
+4% +$758K
QLYS icon
40
Qualys
QLYS
$6.35B
$19.6M 0.79%
199,499
+21,509
+12% +$2.3M
PGTI
41
DELISTED
PGT, Inc.
PGTI
$19.5M 0.79%
1,114,774
+91,216
+9% +$1.6M
BSTC
42
DELISTED
BioSpecifics Technologies Corp.
BSTC
$19.5M 0.79%
369,359
+56,634
+18% +$3.5M
GBT
43
DELISTED
Global Blood Therapeutics, Inc.
GBT
$17.7M 0.71%
320,927
+81,320
+34% +$5.17M
CSOD
44
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$17.3M 0.7%
475,286
+21,145
+5% +$760K
OZK icon
45
Bank OZK
OZK
$5.61B
$16.9M 0.68%
793,693
+43,029
+6% +$1M
RETA
46
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$16.9M 0.68%
173,292
+45,654
+36% +$5.7M
WIFI
47
DELISTED
Boingo Wireless, Inc.
WIFI
$16.8M 0.68%
1,650,834
+139,943
+9% +$1.81M
AERI
48
DELISTED
Aerie Pharmaceuticals
AERI
$16.6M 0.67%
1,412,178
+155,260
+12% +$1.89M
TFX icon
49
Teleflex
TFX
$5.98B
$15.8M 0.64%
46,535
+5,723
+14% +$2.12M
INSM icon
50
Insmed
INSM
$28.6B
$15.5M 0.62%
482,007
+55,111
+13% +$1.58M

Similar funds

Rice Hall James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Rice Hall James & Associates held 291 positions worth $2.48B, up 6.5% from $2.33B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q3 2020 filing shows 33 new, 134 increased, 93 reduced and 18 closed positions. Its largest new stake was Fate Therapeutics: 326,844 shares worth $13.1M. The largest sale was Trade Desk, an estimated $28.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q3 2020 buy was Fate Therapeutics: 326,844 shares worth $13.1M.
  • Rice Hall James & Associates added most to Ziff Davis in Q3 2020, an estimated $32.7M increase.
  • Rice Hall James & Associates's biggest Q3 2020 reduction was Trade Desk, cutting an estimated $28.2M.
  • Rice Hall James & Associates fully exited Aerojet Rocketdyne Holdings in Q3 2020, selling an estimated $8.48M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $2.48B portfolio in Q3 2020.
  • Rice Hall James & Associates opened 33 new positions and closed 18 in Q3 2020.
  • Rice Hall James & Associates's portfolio value rose 6.5% quarter-over-quarter to $2.48B.

Based on Rice Hall James & Associates's 13F filing for Q3 2020, filed 16 Nov 2020.